Cas no 86620-62-4 (4-(4-Methylpiperazin-1-yl)benzoic acid)

4-(4-Methylpiperazin-1-yl)benzoic acid structure
86620-62-4 structure
Product Name:4-(4-Methylpiperazin-1-yl)benzoic acid
CAS No:86620-62-4
MF:C12H16N2O2
MW:220.267642974854
MDL:MFCD02682063
CID:61006
PubChem ID:172089067
Update Time:2024-10-26

4-(4-Methylpiperazin-1-yl)benzoic acid Chemical and Physical Properties

Names and Identifiers

    • 4-(4-Methylpiperazin-1-yl)benzoic acid
    • 4-(4-Methylpiperazinyl)benzoic Acid
    • 4-(4-Methyl-piperazin-1-yl)-benzoic acid
    • 4-(4-methylpiperazino)benzoic acid
    • 1-(4-Carboxyphenyl)-4-methylpiperazine
    • 4-(4-Methylpiperazino) benzoic acid
    • Benzoic acid, 4-(4-methyl-1-piperazinyl)-
    • 4-(4-Methyl-piperazino)benzoic acid
    • 4-(4-METHYL-1-PIPERAZINYL)BENZOIC ACID
    • PubChem10481
    • Oprea1_658124
    • Oprea1_607890
    • KSC448O3P
    • UCFZVQHKTRSZMM-UHFFFAOYSA-N
    • Z
    • 4-(4-Methyl-1-piperazinyl)benzoic acid (ACI)
    • 4-(1-Methylpiperazin-4-yl)benzoic acid
    • AC-3057
    • PB29214
    • SY003702
    • 354813-15-3
    • Q27451684
    • 4-(4-methylpiperazin-1-yl)benzoicacid
    • SCHEMBL63450
    • DB-023132
    • SDCCGMLS-0066014.P001
    • PS-4294
    • M2267
    • CS-W014249
    • 4-(4-methylpiperazino)benzoic acid, AldrichCPR
    • CHEMBL2326882
    • AF-399/15540221
    • AC-3077
    • MFCD02682063
    • AKOS000260180
    • J-513549
    • 86620-62-4
    • 14N
    • DTXSID20353060
    • BDBM50490491
    • 4-(4-methylpiperazin-1-yl) benzoic acid
    • DB-305057
    • EN300-5505504
    • BP-10865
    • MDL: MFCD02682063
    • Inchi: 1S/C12H16N2O2/c1-13-6-8-14(9-7-13)11-4-2-10(3-5-11)12(15)16/h2-5H,6-9H2,1H3,(H,15,16)
    • InChI Key: UCFZVQHKTRSZMM-UHFFFAOYSA-N
    • SMILES: O=C(C1C=CC(N2CCN(C)CC2)=CC=1)O

Computed Properties

  • Exact Mass: 220.12100
  • Monoisotopic Mass: 220.121178
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 16
  • Rotatable Bond Count: 2
  • Complexity: 241
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 43.8
  • XLogP3: -0.9

Experimental Properties

  • Color/Form: White to Yellow Solid
  • Density: 1.188
  • Melting Point: 230°C(lit.)
  • Boiling Point: 393.9°C at 760 mmHg
  • Flash Point: 192.1℃
  • PSA: 43.78000
  • LogP: 1.13950

4-(4-Methylpiperazin-1-yl)benzoic acid Security Information

4-(4-Methylpiperazin-1-yl)benzoic acid Customs Data

  • HS CODE:2933599090
  • Customs Data:

    China Customs Code:

    2933599090

    Overview:

    2933599090. Other compounds with pyrimidine ring in structure(Including other compounds with piperazine ring on the structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4-(4-Methylpiperazin-1-yl)benzoic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
M830577-25g
4-(4-Methyl-piperazin-1-yl)-benzoic acid
86620-62-4 98%
25g
723.00 2021-05-17
Matrix Scientific
033210-500mg
4-(4-Methyl-piperazin-1-yl)-benzoic acid
86620-62-4
500mg
$92.00 2023-09-11
Matrix Scientific
033210-1g
4-(4-Methyl-piperazin-1-yl)-benzoic acid
86620-62-4
1g
$140.00 2023-09-11
Matrix Scientific
033210-5g
4-(4-Methyl-piperazin-1-yl)-benzoic acid
86620-62-4
5g
$425.00 2023-09-11
TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd.
M2267-5G
4-(4-Methylpiperazinyl)benzoic Acid
86620-62-4 >98.0%(T)(HPLC)
5g
¥590.00 2024-04-15
TRC
M218810-10mg
4-(4-Methylpiperazin-1-yl)benzoic Acid
86620-62-4
10mg
$ 50.00 2022-06-04
TRC
M218810-50mg
4-(4-Methylpiperazin-1-yl)benzoic Acid
86620-62-4
50mg
$ 65.00 2022-06-04
TRC
M218810-100mg
4-(4-Methylpiperazin-1-yl)benzoic Acid
86620-62-4
100mg
$ 80.00 2022-06-04
SHANG HAI YI EN HUA XUE JI SHU Co., Ltd.
R032783-1g
4-(4-Methylpiperazin-1-yl)benzoic acid
86620-62-4 98%
1g
¥35 2024-05-21
SHANG HAI YI EN HUA XUE JI SHU Co., Ltd.
R032783-25g
4-(4-Methylpiperazin-1-yl)benzoic acid
86620-62-4 98%
25g
¥381 2024-05-21

4-(4-Methylpiperazin-1-yl)benzoic acid Production Method

Production Method 1

Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: Methanol ,  Water ;  rt; 1 h, 80 °C
1.2 Reagents: Hydrochloric acid Solvents: Water ;  pH 3 - 4
Reference
Design, synthesis and biological evaluation of novel 1H-1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors via fragment-based virtual screening
Liu, Jian; et al, Journal of Enzyme Inhibition and Medicinal Chemistry, 2020, 35(1), 72-84

Production Method 2

Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: Methanol ,  Water ;  2 h, rt
1.2 Reagents: Hydrochloric acid Solvents: Water ;  acidified, rt
Reference
Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer
Han, Xin ; et al, Journal of Medicinal Chemistry, 2021, 64(17), 12831-12854

Production Method 3

Reaction Conditions
1.1 Solvents: Dimethyl sulfoxide ;  36 h, 80 °C
Reference
Synthesis and thermal rearrangement of tertiary amine oxides derived from substituted piperazine
Saeed, May S.; et al, Chemica Sinica, 2012, 3(2), 292-298

Production Method 4

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Dimethyl sulfoxide ;  14 - 25 h, 120 °C
2.1 Reagents: Sodium hydroxide Solvents: Ethanol ,  Water ;  3 - 5 h, 70 °C; 70 °C → rt
2.2 Reagents: Hydrochloric acid Solvents: Water ;  acidified, 0 °C
Reference
Discovery of Substituted 1H-Pyrazolo[3,4-b]pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors
Zhao, Bin; et al, ACS Medicinal Chemistry Letters, 2016, 7(6), 629-634

Production Method 5

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Dimethylformamide ;  2 h, 60 °C
2.1 Reagents: Sodium hydroxide Solvents: Methanol ,  Water ;  2 h, rt
2.2 Reagents: Hydrochloric acid Solvents: Water ;  acidified, rt
Reference
Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer
Han, Xin ; et al, Journal of Medicinal Chemistry, 2021, 64(17), 12831-12854

Production Method 6

Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: Ethanol ,  Water ;  3 - 5 h, 70 °C; 70 °C → rt
1.2 Reagents: Hydrochloric acid Solvents: Water ;  acidified, 0 °C
Reference
Discovery of Substituted 1H-Pyrazolo[3,4-b]pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors
Zhao, Bin; et al, ACS Medicinal Chemistry Letters, 2016, 7(6), 629-634

Production Method 7

Reaction Conditions
1.1 Reagents: Tetrabutylammonium bromide Catalysts: Nickel(2+), tris(2,2′-bipyridine-κN1,κN1′)-, bromide (1:2), (OC-6-11)- Solvents: Dimethylacetamide ;  3 - 6 h, rt
Reference
Expanding Reactivity in DNA-Encoded Library Synthesis via Reversible Binding of DNA to an Inert Quaternary Ammonium Support
Flood, Dillon T.; et al, Journal of the American Chemical Society, 2019, 141(25), 9998-10006

Production Method 8

Reaction Conditions
1.1 Reagents: Hydrochloric acid ;  100 °C
Reference
3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity
Setti, Eduardo L.; et al, Bioorganic & Medicinal Chemistry Letters, 2005, 15(5), 1529-1534

Production Method 9

Reaction Conditions
Reference
Carboxylic acid derivatives and drugs containing them
, Federal Republic of Germany, , ,

Production Method 10

Reaction Conditions
1.1 Solvents: Dimethylformamide ;  100 °C
2.1 Reagents: Hydrochloric acid ;  100 °C
Reference
3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity
Setti, Eduardo L.; et al, Bioorganic & Medicinal Chemistry Letters, 2005, 15(5), 1529-1534

Production Method 11

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: Dimethyl sulfoxide ;  rt → 110 °C; 10 h, 110 °C
2.1 Reagents: Sodium hydroxide Solvents: Methanol ,  Water ;  rt; 1 h, 80 °C
2.2 Reagents: Hydrochloric acid Solvents: Water ;  pH 3 - 4
Reference
Design, synthesis and biological evaluation of novel 1H-1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors via fragment-based virtual screening
Liu, Jian; et al, Journal of Enzyme Inhibition and Medicinal Chemistry, 2020, 35(1), 72-84

4-(4-Methylpiperazin-1-yl)benzoic acid Raw materials

4-(4-Methylpiperazin-1-yl)benzoic acid Preparation Products

Recommended suppliers
Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Henan Dongyan Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Henan Dongyan Pharmaceutical Co., Ltd
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
ASIACHEM I&E (JIANGSU) CO., LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
ASIACHEM I&E (JIANGSU) CO., LTD
Shenzhen Yaoyuan R&D Center Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shenzhen Yaoyuan R&D Center Co.,Ltd